EQUITY INVESTMENT CORP has added 3,608,849 shares of $DOC to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 09-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $DOC.
HEALTHPEAK PROPERTIES Hedge Fund Activity
We have seen 381 institutional investors add shares of HEALTHPEAK PROPERTIES stock to their portfolio, and 373 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 8,209,933 shares (-89.1%) from their portfolio in Q2 2025, for an estimated $143,755,926
- BLACKROCK, INC. removed 6,838,974 shares (-8.4%) from their portfolio in Q2 2025, for an estimated $119,750,434
- DEUTSCHE BANK AG\ removed 4,880,704 shares (-57.5%) from their portfolio in Q2 2025, for an estimated $85,461,127
- FULLER & THALER ASSET MANAGEMENT, INC. added 4,738,623 shares (+25.8%) to their portfolio in Q2 2025, for an estimated $82,973,288
- NORDEA INVESTMENT MANAGEMENT AB removed 3,859,078 shares (-98.4%) from their portfolio in Q3 2025, for an estimated $73,901,343
- RESOLUTION CAPITAL LTD removed 3,811,782 shares (-51.9%) from their portfolio in Q2 2025, for an estimated $66,744,302
- CITADEL ADVISORS LLC added 3,610,732 shares (+inf%) to their portfolio in Q2 2025, for an estimated $63,223,917
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HEALTHPEAK PROPERTIES Insider Trading Activity
HEALTHPEAK PROPERTIES insiders have traded $DOC stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $DOC stock by insiders over the last 6 months:
- TOMMY G THOMPSON has made 2 purchases buying 11,477 shares for an estimated $198,742 and 0 sales.
- SCOTT M BRINKER (President and CEO) has made 4 purchases buying 10,043 shares for an estimated $172,875 and 0 sales.
- JOHN T THOMAS purchased 1,450 shares for an estimated $24,729
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HEALTHPEAK PROPERTIES Congressional Stock Trading
Members of Congress have traded $DOC stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $DOC stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/17 and 1 sale worth up to $15,000 on 08/04.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 05/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HEALTHPEAK PROPERTIES Analyst Ratings
Wall Street analysts have issued reports on $DOC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Raymond James issued a "Outperform" rating on 09/15/2025
- Morgan Stanley issued a "Overweight" rating on 08/22/2025
- Baird issued a "Outperform" rating on 07/30/2025
To track analyst ratings and price targets for HEALTHPEAK PROPERTIES, check out Quiver Quantitative's $DOC forecast page.
HEALTHPEAK PROPERTIES Price Targets
Multiple analysts have issued price targets for $DOC recently. We have seen 8 analysts offer price targets for $DOC in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Richard Anderson from Cantor Fitzgerald set a target price of $20.0 on 10/01/2025
- Jonathan Hughes from Raymond James set a target price of $20.0 on 09/15/2025
- John Kilichowski from Wells Fargo set a target price of $18.0 on 08/27/2025
- Richard Hill from Morgan Stanley set a target price of $21.0 on 08/22/2025
- Omotayo Okusanya from Deutsche Bank set a target price of $18.0 on 08/20/2025
- Amanda Sweitzer from Baird set a target price of $21.0 on 07/30/2025
- Nicholas Yulico from Scotiabank set a target price of $19.0 on 07/29/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $DOC ticker page for more data.
